RDS develops solutions for continuous and remote patient monitoring to improve patient pathways in healthcare.
RDS has raised $16.4M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
RDS's investors include Bpifrance, Critical Path Ventures, MACSF, Capital Grand Est, Sam Eletr Trust.
RDS is headquartered in Strasbourg, France.
RDS develops solutions for continuous and remote patient monitoring to improve patient pathways in healthcare.
RDS is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RDS — Funding & Investors." VCBacked, September 29, 2025, https://www.vcbacked.co/company/rds. Accessed July 23, 2026.
VCBacked. (2025). RDS — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/rds
{{cite web |title=RDS — Funding & Investors |url=https://www.vcbacked.co/company/rds |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated